carvedilol has been researched along with osteoprotegerin in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
de Araújo Júnior, RF; de Araújo, AA; de Lucena, HF; de Medeiros, CA; de Souza, LB; do Socorro Costa Feitosa Alves, M; Freitas, Mde L; Souza, TO | 1 |
1 other study(ies) available for carvedilol and osteoprotegerin
Article | Year |
---|---|
Carvedilol decrease IL-1β and TNF-α, inhibits MMP-2, MMP-9, COX-2, and RANKL expression, and up-regulates OPG in a rat model of periodontitis.
Topics: Animals; Carbazoles; Carvedilol; Cyclooxygenase 2; Disease Models, Animal; Interleukin-1beta; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Osteoprotegerin; Oxidative Stress; Periodontitis; Propanolamines; RANK Ligand; Rats; Tumor Necrosis Factor-alpha | 2013 |